Lori E. Dodd

National Institute of Allergy and Infectious Diseases

MathematicsMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Remdesivir for the Treatment of Covid-19 — Final Report”.

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine(2020)10.1056/nejmoa2007764

N/A

12.3DataRank · unranked

7738 citations

Kay M Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, André C. Kalil +35 more

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

European Journal of Cancer(2009)10.1016/j.ejca.2008.10.026

N/A

1.5DataRank · unranked

29148 citations

P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford +25 more

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

Wellcome Open Research(2021)10.12688/wellcomeopenres.16783.1

N/A

0.554DataRank · unranked

13 citations

Sean Wasserman, Mpumi Maxebengula, Cari Stek, Marise Bremer, Remy Daroowala +33 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198

N/A

0.439DataRank · unranked

13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

Annals of Internal Medicine(2024)10.7326/m23-2593

N/A

0.376DataRank · unranked

6 citations

Jing Wang, Kay M. Tomashek, Tyler Bonnett, Kanal Singh, Vincent C. Marconi +16 more

Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data

Clinical Infectious Diseases(2021)10.1093/cid/ciab695

N/A

0DataRank · unranked

17 citations

Shannon Gallagher, Rekha R. Rapaka, Richard T. Davey, Sarah B. Doernberg, Robert Grossberg +11 more

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization

Clinical Infectious Diseases(2021)10.1093/cid/ciab712

N/A

0DataRank · unranked

16 citations

Tyler Bonnett, Daniel A. Sweeney, Nikhil Huprikar, Anuradha Ganesan, Maria G. Frank +5 more

Monitoring Immune Activation with Whole-Body Fluorodeoxyglucose–Positron-Emission Tomography in Simian Immunodeficiency Virus–Infected Rhesus Macaques

ImmunoHorizons(2021)10.4049/immunohorizons.2100043

N/A

0DataRank · unranked

3 citations

Sharat Srinivasula, William Schreiber-Stainthorp, Swati Shah, Paula DeGrange, Andrew Bonvillain +6 more

Immune correlates analysis using vaccinees from test negative designs

Biostatistics(2020)10.1093/biostatistics/kxaa037

N/A

0DataRank · unranked

9 citations

Lori E. Dodd, Dean Follmann

Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)

PLoS ONE(2022)10.1371/journal.pone.0273914

N/A

0DataRank · unranked

9 citations

Kathryn Shaw‐Saliba, Lori E. Dodd, Robin Dewar, Sylvain Laverdure, Shawn T. Brown +49 more

Counting Monkeypox Lesions in Patient Photographs: Limits of Agreement of Manual Counts and Artificial Intelligence

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.08.044

N/A

0DataRank · unranked

7 citations

David W. House, Placide Mbala‐Kingebeni, Olivier Tshiani Mbaya, Lori E. Dodd, Edward W. Cowen +7 more

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00528-8

N/A

0DataRank · unranked

125 citations

Benjamin Speich, France Mentré, Corina S. Rueegg, Drifa Belhadi, Lambert Assoumou +30 more

Beware of drug resistance: Let’s not lose tecovirimat against mpox

Clinical Microbiology and Infection(2023)10.1016/j.cmi.2023.09.014

N/A

0DataRank · unranked

6 citations

Ian Crozier, Koen Vercauteren, Isabel Brosius, Placide Mbala‐Kingebeni, Lori E. Dodd +6 more

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad290

N/A

0DataRank · unranked

2 citations

Noreen A. Hynes, Corri B. Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg +37 more

PET/CT guided tuberculosis treatment shortening: a randomized trial

medRxiv(2024)10.1101/2024.10.03.24314723

N/A

0DataRank · unranked

10 citations

Ray Y. Chen, Xiang Yu, Bronwyn Smith, Xin Liu, Jingcai Gao +50 more

Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study

The Lancet(2025)10.1016/s0140-6736(25)02309-8

N/A

0DataRank · unranked

5 citations

Isaac Barhishindi, Ange Mubiala, Espoir Bwenge Malembaka, Lydia Braunack-Mayer, Bruce Nganga +92 more

Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial

Clinical Trials(2025)10.1177/17407745251313928

N/A

0DataRank · unranked

1 citations

Gail E. Potter, Lori E. Dodd, Tyler Bonnett

Endpoints for randomized controlled clinical trials for COVID-19 treatments

Clinical Trials(2020)10.1177/1740774520939938

N/A

0DataRank · unranked

4 citations

Dean Follmann, Jing Wang, Franz Koenig, Lisa L. Korn, Christian Schoergenhofer +10 more

Mpox lesion counting with semantic and instance segmentation methods

Journal of Medical Imaging(2025)10.1117/1.jmi.12.3.034506

N/A

0DataRank · unranked

0 citations

Andrew McNeil, Yihao Liu, David W. House, Placide Mbala‐Kingebeni, Olivier Tshiani Mbaya +10 more

Predicting TB treatment outcomes using baseline risk and treatment response markers: developing the PredictTB early treatment completion criteria

Gates Open Research(2020)10.12688/gatesopenres.13179.1

N/A

0DataRank · unranked

0 citations

Jing Wang, Lili Liang, Yingda L. Xie, Stephanus T. Malherbe, Jill Winter +9 more

Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis

Science Translational Medicine(2021)10.1126/scitranslmed.abd7618

N/A

0DataRank · unranked

47 citations

Veronique de Jager, Ray Y. Chen, Lori E. Dodd, Praveen Paripati, Laura E. Via +19 more